- Home
- PESI vs BDTX Comparison
PESI vs BDTX Comparison
Compare PESI & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- BDTX
- Stock Information
- Founded
- PESI 1990
- BDTX 2014
- Country
- PESI United States
- BDTX United States
- Employees
- PESI N/A
- BDTX N/A
- Industry
- PESI Environmental Services
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PESI Industrials
- BDTX Health Care
- Exchange
- PESI Nasdaq
- BDTX Nasdaq
- Market Cap
- PESI 205.4M
- BDTX 181.4M
- IPO Year
- PESI 1992
- BDTX 2020
- Fundamental
- Price
- PESI $12.16
- BDTX $3.05
- Analyst Decision
- PESI
- BDTX Strong Buy
- Analyst Count
- PESI 0
- BDTX 6
- Target Price
- PESI N/A
- BDTX $12.50
- AVG Volume (30 Days)
- PESI 95.7K
- BDTX 800.3K
- Earning Date
- PESI 08-07-2025
- BDTX 11-04-2025
- Dividend Yield
- PESI N/A
- BDTX N/A
- EPS Growth
- PESI N/A
- BDTX N/A
- EPS
- PESI N/A
- BDTX 0.25
- Revenue
- PESI $60,019,000.00
- BDTX $70,000,000.00
- Revenue This Year
- PESI $8.35
- BDTX N/A
- Revenue Next Year
- PESI $82.81
- BDTX N/A
- P/E Ratio
- PESI N/A
- BDTX $12.18
- Revenue Growth
- PESI N/A
- BDTX N/A
- 52 Week Low
- PESI $6.25
- BDTX $1.20
- 52 Week High
- PESI $16.25
- BDTX $6.33
- Technical
- Relative Strength Index (RSI)
- PESI 58.13
- BDTX 61.59
- Support Level
- PESI $11.33
- BDTX $2.56
- Resistance Level
- PESI $12.21
- BDTX $2.95
- Average True Range (ATR)
- PESI 0.42
- BDTX 0.16
- MACD
- PESI 0.01
- BDTX 0.02
- Stochastic Oscillator
- PESI 75.00
- BDTX 100.00
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.